These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15834950)

  • 1. Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector.
    Maranga L; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2005 Jun; 90(5):645-55. PubMed ID: 15834950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
    Xie L; Pilbrough W; Metallo C; Zhong T; Pikus L; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2002 Dec; 80(5):569-79. PubMed ID: 12355468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of higher passage PER.C6 cells for adenovirus manufacture.
    Berdichevsky M; Gentile MP; Hughes B; Meis P; Peltier J; Blumentals I; Auniņs J; Altaras NE
    Biotechnol Prog; 2008; 24(1):158-65. PubMed ID: 18052336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels.
    Maranga L; Goochee CF
    Biotechnol Bioeng; 2006 May; 94(1):139-50. PubMed ID: 16523524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.
    Ferreira TB; Ferreira AL; Carrondo MJ; Alves PM
    J Biotechnol; 2005 Sep; 119(3):272-80. PubMed ID: 15885836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different serum-free media and osmolality effect upon human 293 cell growth and adenovirus production.
    Ferreira TB; Ferreira AL; Carrondo MJ; Alves PM
    Biotechnol Lett; 2005 Nov; 27(22):1809-13. PubMed ID: 16314975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Conceição MM; Tonso A; Freitas CB; Pereira CA
    Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration.
    Subramanian S; Altaras GM; Chen J; Hughes BS; Zhou W; Altaras NE
    Biotechnol Prog; 2005; 21(3):851-9. PubMed ID: 15932265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
    Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
    J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.
    Henry O; Dormond E; Perrier M; Kamen A
    Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.
    Genzel Y; Behrendt I; König S; Sann H; Reichl U
    Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of culture passages on growth kinetics and adenovirus vector production for gene therapy in monolayer and suspension cultures of HEK 293 cells.
    Park MT; Lee MS; Kim SH; Jo EC; Lee GM
    Appl Microbiol Biotechnol; 2004 Oct; 65(5):553-8. PubMed ID: 15168091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical model of influenza A virus production in large-scale microcarrier culture.
    Möhler L; Flockerzi D; Sann H; Reichl U
    Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.